STAT+: Government workers feel the squeeze on health care
Get the Health newsletter
Daily health & science — research, biotech, public health, the studies worth knowing. Free.
- States face a Sept. 30 deadline to decide whether to join a federal Medicaid 'most-favored nation' drug pricing program that would grant them the lowest prices available to other major payers
- Margaret Manto is joining STAT to cover the FDA, while Nick Florko returns to launch a new beat on declining trust in science after previously founding STAT's commercial determinants of health beat and launching the D.C. Diagnosis newsletter in 2019
Why it matters: The Sept. 30 deadline forces governors and Medicaid directors to quickly decide whether to tie their state's drug spending to the lowest prices negotiated elsewhere, a choice with direct implications for state pharmacy budgets and Medicaid beneficiary access to medications.
Ask SkimNews
